1832 Asset Management’s AngioDynamics ANGO Stock Holding History

1832 Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50	Closed	-$1K	–	673
2019 Q4	$1K	Buy	+50	New	+$764	﹤0.01%	656

Other funds holding ANGO

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

1832 Asset Management's ANGO Position: Q1 2020 in Review

1832 Asset Management sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 50 shares — an estimated $1K sold.

1832 Asset Management first reported a position in ANGO in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.

1832 Asset Management reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
1832 Asset Management sold 50 AngioDynamics shares in Q1 2020, an estimated $1K.
1832 Asset Management first reported a position in AngioDynamics in Q4 2019 and held it in 1 quarter.
1832 Asset Management's AngioDynamics position peaked at $1K in Q4 2019.
158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.

Based on 1832 Asset Management's 13F filing for Q1 2020, filed 14 May 2020.